NCT07573930

Brief Summary

The goal of this observational study is to investigate how a standard dose of the drug dexamethasone affects blood sugar levels during and after non-cardiac surgery in adult patients. The main questions it aims to answer are:

  • How does dexamethasone influence blood sugar levels in patients undergoing non-cardiac surgery?
  • Does continuous glucose monitoring (CGM) provide a more accurate estimate of blood sugar fluctuations compared to traditional time-specific finger-prick measurements? Participants are scheduled to receive dexamethasone as part of standard anesthesia care and will undergo their planned surgery. As part of the study, a continuous glucose monitoring (CGM) device will be placed on their upper arm approximately 12 hours before surgery and will remain in place for up to 10 days after the operation. During this period, their blood sugar levels will be measured using both the CGM device and traditional finger-prick tests. CGM readings are blinded for both participants and clinicians. No additional treatments or changes to their standard care will be made as a result of their participation in the study. The study will include 100 adult patients from the Department of Anesthesiology at Sjællands University Hospital, Roskilde.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
32mo left

Started Apr 2026

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Apr 2026Dec 2028

Study Start

First participant enrolled

April 23, 2026

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

April 27, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 7, 2026

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2028

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

May 7, 2026

Status Verified

April 1, 2026

Enrollment Period

2.2 years

First QC Date

April 27, 2026

Last Update Submit

May 4, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Characterization of hyperglycemia I

    Peak glucose level

    Up to 10 days postoperatively

  • Characterization of hyperglycemia II

    Duration of hyperglycemia

    Up to 10 days postoperatively

Secondary Outcomes (2)

  • Correlation between pre- and postoperative glucose trajectories

    Up to 10 days postoperatively

  • Subgroup analyses

    Up to 10 days postoperatively

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult, surgical population where dexamethasone may be administered as part of anesthetic preparation of the patient for surgery.

You may qualify if:

  • Adult patients (≥18 years) scheduled for elective non cardiac surgery
  • Expected surgery duration \>1 hour
  • Administration of dexamethasone as part of standard anaesthetic regimen or planned by the responsible anaesthetist to enhance recovery or to limit risk of PONV.
  • Ability to provide written informed consent

You may not qualify if:

  • Not possible to obtain consent or permission
  • Known allergy or adverse reaction to dexamethasone
  • Type 1 diabetes (due to need for insulin titration)
  • Active infection, sepsis, or immunosuppression
  • Contraindications to continuous glucose monitoring (CGM)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zealand University Hospital

Roskilde, 4000, Denmark

RECRUITING

Study Officials

  • Anne M Brinck, Msc Medicine

    Zealand University Hospital, Roskilde, Denmark

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Anne M Brinck, MSc Medicine

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 27, 2026

First Posted

May 7, 2026

Study Start

April 23, 2026

Primary Completion (Estimated)

July 1, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

May 7, 2026

Record last verified: 2026-04

Locations